Article

Cyclosporine emulsion offers severe dry eye relief

April 14-San Francisco-Cyclosporine ophthalmic emulsion 0.05% drops (Restasis,Allergan), approved 11 days ago, offers relief of dry eye symptoms by treatingthe inflammatory process that causes the condition, explained John D. Sheppard,MD, program and laboratory director, professor, departments of ophthalmologyand pharmacology, Eastern Virginia School of Medicine. He spoke during thesymposium, "Interdisciplinary Perspectives in Corneal Health Integrity,"sponsored by Allergan.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.